STRAFIDA Trademark

Trademark Overview

On Tuesday, April 7, 2015, a trademark application was filed for STRAFIDA with the United States Patent and Trademark Office. The USPTO has given the STRAFIDA trademark a serial number of 79164817. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, May 27, 2022. This trademark is owned by Novo Nordisk Health Care AG. The STRAFIDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for hemostasis management
strafida

General Information

Serial Number79164817
Word MarkSTRAFIDA
Filing DateTuesday, April 7, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, May 27, 2022
Registration Number4848683
Registration DateTuesday, November 10, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 25, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for hemostasis management

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 27, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovo Nordisk Health Care AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovo Nordisk Health Care AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovo Nordisk Health Care AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Wednesday, April 12, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Monday, March 20, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, March 20, 2023INVALIDATION PROCESSED
Friday, January 27, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, May 27, 2022CANCELLED SECTION 71
Saturday, December 4, 2021NEW REPRESENTATIVE AT IB RECEIVED
Sunday, November 21, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, August 6, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, February 5, 2016NOTIFICATION PROCESSED BY IB
Wednesday, January 20, 2016FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, January 20, 2016FINAL DISPOSITION PROCESSED
Thursday, December 10, 2015GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, November 10, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, August 25, 2015PUBLISHED FOR OPPOSITION
Friday, August 21, 2015NOTIFICATION PROCESSED BY IB
Wednesday, August 5, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 5, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 5, 2015NOTICE OF PUBLICATION
Thursday, July 16, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 15, 2015ASSIGNED TO EXAMINER
Tuesday, May 19, 2015APPLICATION FILING RECEIPT MAILED
Friday, May 15, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 14, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

strafida management hemostasis preparations pharmaceutical